SBIR/STTR Research Award

Air Plasma Sterilization Device with Plasma-in-Lumen Technology

Award identifier 20df5cc66aec407a87a0f89b7c10e277588e1f6ff18c27989a383bb2055990bcAwarding agency Department of Health and Human Services · Food and Drug Administration

Award amount

$999,890

Program and phase

SBIR · Phase II

Award year

2025

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Food and Drug Administration
Recipient company
ADVANCED COOLING TECHNOLOGIES INC
Proposal award date
2025-09-30
Contract end date
2027-08-31
UEI
Z8KVZV3DR7J4
Solicitation number
PA23-230
Topic code
FDA

Research abstract

Abstract Flexible endoscopy is widely used in diagnostic and therapeutic procedures for digestive diseases. However, current endoscope sterilization technologies can be labor intensive, have high health and environmental impacts, or have constraints in endoscope dimensions. Specifically, the mainstream approach Ethylene Oxide (EtO) is facing significantly tightened regulations due to its high toxicity and carcinogenicity, and alternatives such as Vaporized Hydrogen Peroxide (VHP) technologies are unable to sterilize lumens with >1 m length while suffering from moisture-induced sterilization failure. To tackle the challenge, Advanced Cooling Technologies, Inc. develops a novel dry air plasma sterilization system that can perform automated endoscope sterilization without lumen length constraints or toxic gas emission. Major innovations include 1) Sheet plasma reactor design that is embedded in a flexible pouch for enhanced sterilization and combined storage; 2) Plasma-in-Lumen technology that directly delivers sterilant into the lumens with arbitrary length; and 3) Chamber-free compact system design that allows a centralized control unit to operate multiple pouches with a flexible sterilization scheduling. Further, the system is compatible with various gas sources, including dry air, oxygen-rich air, and VHP for future commercialization. In Phase I, we conducted a series of prototype development on both the component (pouch reactor and Plasma- in-Lumen technology) and system levels to demonstrate the feasibility of the concept. The sterilization/disinfection of the medical devices was successfully confirmed by the industrial field-standard self- contained biological indicators (SCBIs) inoculated with G. stearothermophilus spores combined with process- challenging devices (PCDs). Our work is the first in the world to successfully confirm air plasma sterilization via SCBI and PCD. We also evaluated alternative gas sources to achieve a sterilization cycle time shorter than that with the VHP system. In potential Phase II, our goal is to develop a full-feature system that can achieve reliable sterilization of endoscopes and other medical devices. Four Aims are strategically designed to achieve this goal: Aim 1) Build a complete sterilization system with all the peripherals including a high-quality, reusable pouch with sheet plasma reactors, Plasma-in-lumen reactors, and all safety and automation components. Aim 2) Perform and validate consistent sterilization performance and long-term material compatibility. Aim 3) Develop high-throughput operations. Aim 4) Explore alternative gas sources. The recently tightened EtO emission regulation provided a unique commercialization potential for alternative approaches such as plasma. Our technology can also be used in other applications such as planetary protection for space missions, etc., further expanding commercialization opportunities with simplified regulatory pathways.

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

282 SBIR/STTR records share this UEI (2003–2026). Reported award amounts total $118,415,811. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Energy, National Science Foundation, Department of Agriculture, Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.